Joell J. Gills

4.0k total citations · 1 hit paper
47 papers, 3.2k citations indexed

About

Joell J. Gills is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joell J. Gills has authored 47 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 17 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joell J. Gills's work include PI3K/AKT/mTOR signaling in cancer (15 papers), Cancer-related Molecular Pathways (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Joell J. Gills is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (15 papers), Cancer-related Molecular Pathways (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Joell J. Gills collaborates with scholars based in United States, Japan and Canada. Joell J. Gills's co-authors include Phillip A. Dennis, Regan M. Memmott, Hiroshi Kitagawa, Courtney A. Granville, Jaclyn LoPiccolo, Shigeru Kawabata, Junji Tsurutani, John M. Pezzuto, Brendan Quinn and Willie Wilson and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Joell J. Gills

46 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer

2015 643 citations Kristin J. Lastwika, Willie Wilson et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joell J. Gills United States	28	2.0k	1.1k	452	390	380	47	3.2k
Junji Magae Japan	33	1.9k 1.0×	841 0.8×	690 1.5×	380 1.0×	318 0.8×	136	3.7k
Chung-Wai Shiau Taiwan	37	2.1k 1.1×	957 0.9×	560 1.2×	374 1.0×	296 0.8×	68	3.4k
Kangdong Liu China	33	2.4k 1.2×	1.0k 0.9×	769 1.7×	401 1.0×	483 1.3×	202	3.9k
Xian‐Jun Qu China	37	2.1k 1.1×	943 0.9×	987 2.2×	550 1.4×	229 0.6×	133	3.9k
Tinghong Ye China	38	1.9k 1.0×	683 0.6×	445 1.0×	468 1.2×	548 1.4×	126	4.1k
Ramzi M. Mohammad United States	41	2.9k 1.5×	1.2k 1.2×	601 1.3×	374 1.0×	218 0.6×	154	4.8k
Panayotis Pantazis United States	36	2.5k 1.3×	1.2k 1.1×	421 0.9×	338 0.9×	212 0.6×	93	3.7k
Ziming Dong China	34	2.1k 1.1×	712 0.7×	692 1.5×	413 1.1×	172 0.5×	127	3.3k
Courtney Nicholas United States	20	1.5k 0.7×	953 0.9×	413 0.9×	706 1.8×	191 0.5×	27	2.9k
Ping Chen China	31	2.1k 1.1×	838 0.8×	728 1.6×	194 0.5×	390 1.0×	125	3.3k

Countries citing papers authored by Joell J. Gills

Since Specialization

Citations

This map shows the geographic impact of Joell J. Gills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joell J. Gills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joell J. Gills more than expected).

Fields of papers citing papers by Joell J. Gills

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joell J. Gills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joell J. Gills. The network helps show where Joell J. Gills may publish in the future.

Co-authorship network of co-authors of Joell J. Gills

This figure shows the co-authorship network connecting the top 25 collaborators of Joell J. Gills. A scholar is included among the top collaborators of Joell J. Gills based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joell J. Gills. Joell J. Gills is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shaikh, Fyza Y., James R. White, Joell J. Gills, et al.. (2021). A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors. Clinical Cancer Research. 27(9). 2571–2583. 27 indexed citations

Osoegawa, Atsushi, Joell J. Gills, Shigeru Kawabata, & Phillip A. Dennis. (2017). Rapamycin sensitizes cancer cells to growth inhibition by the PARP inhibitor olaparib. Oncotarget. 8(50). 87044–87053. 17 indexed citations

Lastwika, Kristin J., Willie Wilson, Qing Kay Li, et al.. (2015). Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer. Cancer Research. 76(2). 227–238. 643 indexed citations breakdown →

Doğan, İrem, Shigeru Kawabata, Emily Anne Smith Bergbower, et al.. (2014). SOX2 expression is an early event in a murine model of EGFR mutant lung cancer and promotes proliferation of a subset of EGFR mutant lung adenocarcinoma cell lines. Lung Cancer. 85(1). 1–6. 25 indexed citations

Quinn, Brendan, Matthew C. Dallos, Hiroshi Kitagawa, et al.. (2013). Inhibition of Lung Tumorigenesis by Metformin Is Associated with Decreased Plasma IGF-I and Diminished Receptor Tyrosine Kinase Signaling. Cancer Prevention Research. 6(8). 801–810. 68 indexed citations

Quinn, Brendan, Hiroshi Kitagawa, Regan M. Memmott, Joell J. Gills, & Phillip A. Dennis. (2013). Repositioning metformin for cancer prevention and treatment. Trends in Endocrinology and Metabolism. 24(9). 469–480. 232 indexed citations

Kawabata, Shigeru, Joell J. Gills, Jaclyn LoPiccolo, et al.. (2012). Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells. Cell Death and Disease. 3(7). e353–e353. 59 indexed citations

Zhang, Chunyu, Abdel Elkahloun, Hongling Liao, et al.. (2011). Expression Signatures of the Lipid-Based Akt Inhibitors Phosphatidylinositol Ether Lipid Analogues in NSCLC Cells. Molecular Cancer Therapeutics. 10(7). 1137–1148. 10 indexed citations

Zhang, Chunyu, Abdel Elkahloun, Matthew Robertson, et al.. (2011). Loss of Cytoplasmic CDK1 Predicts Poor Survival in Human Lung Cancer and Confers Chemotherapeutic Resistance. PLoS ONE. 6(8). e23849–e23849. 48 indexed citations

10.

Gills, Joell J. & Phillip A. Dennis. (2009). Perifosine: Update on a novel Akt inhibitor. Current Oncology Reports. 11(2). 102–110. 188 indexed citations

11.

Gills, Joell J., Jaclyn LoPiccolo, & Phillip A. Dennis. (2008). Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy. Autophagy. 4(1). 107–109. 107 indexed citations

12.

Gills, Joell J., Jaclyn LoPiccolo, Junji Tsurutani, et al.. (2007). Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo. Clinical Cancer Research. 13(17). 5183–5194. 264 indexed citations

13.

Thole, Julie M., Young-Hwa Kang, Joell J. Gills, et al.. (2006). A Comparative Evaluation of the Anticancer Properties of European and American Elderberry Fruits. Journal of Medicinal Food. 9(4). 498–504. 51 indexed citations

14.

Granville, Courtney A., Regan M. Memmott, Joell J. Gills, & Phillip A. Dennis. (2006). Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway. Clinical Cancer Research. 12(3). 679–689. 145 indexed citations

15.

Gills, Joell J., Elizabeth H. Jeffery, Nathan V. Matusheski, et al.. (2005). Sulforaphane prevents mouse skin tumorigenesis during the stage of promotion. Cancer Letters. 236(1). 72–79. 96 indexed citations

16.

Gills, Joell J., Jerome W. Kosmeder, R C Moon, Daniel D. Lantvit, & John M. Pezzuto. (2005). Effect of Deguelin on UVB-Induced Skin Carcinogenesis. Journal of Chemotherapy. 17(3). 297–301. 9 indexed citations

17.

Cuendet, Muriel, Joell J. Gills, & John M. Pezzuto. (2004). Brusatol-induced HL-60 cell differentiation involves NF-κB activation. Cancer Letters. 206(1). 43–50. 34 indexed citations

18.

Gills, Joell J. & Phillip A. Dennis. (2004). The development of phosphatidylinositol ether lipid analogues as inhibitors of the serine/threonine kinase, Akt. Expert Opinion on Investigational Drugs. 13(7). 787–797. 37 indexed citations

19.

Chang, Leng Chee, Joell J. Gills, Krishna Bhat, et al.. (2000). Activity-guided isolation of constituents of Cerbera manghas with antiproliferative and antiestrogenic activities. Bioorganic & Medicinal Chemistry Letters. 10(21). 2431–2434. 34 indexed citations

20.

Ingólfsdóttir, Kristı́n, Sang Kook Lee, Krishna Bhat, et al.. (2000). Evaluation Of Selected Lichens From Iceland For Cancer Chemopreventive And Cytotoxic Activity. Pharmaceutical Biology. 38(4). 313–317. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact